Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression. [electronic resource]
Producer: 20181211Description: 1335-1344 p. digitalISSN:- 0925-4439
- Aged
- Aged, 80 and over
- Animals
- Bile Acids and Salts -- metabolism
- Bile Duct Neoplasms -- drug therapy
- Bile Ducts -- cytology
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Chenodeoxycholic Acid -- analogs & derivatives
- Cholangiocarcinoma -- drug therapy
- Cholic Acids -- pharmacology
- Cohort Studies
- Disease Progression
- Energy Metabolism -- drug effects
- Epithelial Cells -- metabolism
- Female
- Gastrointestinal Agents -- pharmacology
- Humans
- Male
- Mice
- Mice, Nude
- Middle Aged
- Mitochondria -- drug effects
- Receptors, Cytoplasmic and Nuclear -- agonists
- Receptors, G-Protein-Coupled -- agonists
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.